TCTMD
@tctmd.bsky.social
930 followers 110 following 990 posts
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at http://tctmd.com
Posts Media Videos Starter Packs
Reposted by TCTMD
crfheart.bsky.social
✨ AI is changing everything, and healthcare is no exception. Join us for a visionary #TCT2025 keynote address as Dr. Robert Wachter shares bold insights from his new book “A Giant Leap.” Discover what AI means for the future of medicine & how you can navigate this new era! https://ow.ly/BCge50X9Yi5
tctmd.bsky.social
The PCSK9 inhibitor evolocumab reduces the risk of MACE better than standard therapy alone in people with no previous history of CV events, based on data from the VESALIUS-CV trial. Read more here: www.tctmd.com/news/evolocu...
Evolocumab Wins for Primary Prevention in VESALIUS-CV
The 12,000-patient trial of the PCSK9 inhibitor met its primary endpoints in high-risk individuals with no prior CV events.
www.tctmd.com
tctmd.bsky.social
Juan Granada discusses potential pharmacologic therapies that may impact the progression of aortic stenosis with Marc Dweck in the latest episode of Heart Valve Matters. www.tctmd.com/audio/medica...
Reposted by TCTMD
crfheart.bsky.social
💡 Want a front-row seat to cutting-edge research? Join Dr. Timothy Henry on 10/28 when he reveals findings from a multicenter registry examining AI-enabled ECG interpretation in STEMI.

🔍 Don’t miss the full lineup of late-breaking trials & science! www.tctconference.com/late-breakin...

#CardioSky
Reposted by TCTMD
crfheart.bsky.social
#Innovation that matters. #TCT2025 brings together the science, strategy, and global collaboration to transform heart care.

Don’t miss your chance to be part of it all! www.tctconference.com/register

#CardioSky
tctmd.bsky.social
Nearly all patients who develop CVD have at least one traditional risk factor, according to a new analysis. Risks include MI, heart failure, coronary heart disease, stroke, and higher cholesterol. More here: www.tctmd.com/news/risk-fa...
Risk Factors Present in Nearly All Patients Who Develop CVD
Keeping these factors in check and adhering to the AHA’s Life’s Essential 8, is the best way to prevent CVD, say researchers.
www.tctmd.com
Reposted by TCTMD
yaelmaxwell.bsky.social
Looking forward to being at #EACTS2025. Full coverage to come on @tctmd.bsky.social
tctmd.bsky.social
In this episode of Rox Heart Radio, Roxana Mehran sits down with TCT award winners Kenneth Rosenfield and Stephan Windecker. Listen now: www.tctmd.com/audio/meet-t...
tctmd.bsky.social
A new scientific statement from @americanheart.bsky.social encourages cardiologists and other healthcare practitioners to emphasize the importance of psychological health and well-being for patients during post-MI recovery. More here: www.tctmd.com/news/recogni...
Recognize and Enable Care for Post-MI Psychological Distress: AHA
It can be a sensitive topic for patients that should be broached gently, without confrontation or judgment, the committee notes.
www.tctmd.com
tctmd.bsky.social
From new @escardio.bsky.social valve guidelines to headlines from this year's #ESC2025 Congress, read all the top news stories to come out of TCTMD in September. www.tctmd.com/news/tctmds-...
tctmd.bsky.social
The Integra-D trial introduced a novel implantable device that provides both cardiac contractility modulation as well as defibrillation. The device successfully and safely delivers integrated therapy while also improving symptoms for HFrEF patients. www.tctmd.com/news/ccm-d-d...
CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF
The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms.
www.tctmd.com
Reposted by TCTMD
crfheart.bsky.social
🔍Explore groundbreaking content and start charting your course to cardiovascular innovation with the #TCT2025 Program Guide!🫀 https://ow.ly/VZkt50X6pMC

Not registered yet? Secure your spot now! https://ow.ly/EIK350X6pMA

#CardioSky #MedSky
tctmd.bsky.social
A new @accintouch.bsky.social‬ consensus document aids clinicians on issues around tricuspid regurgitation. It covers all aspects of management from initial evaluation to long-term follow-up as well as medical, surgical, and transcatheter treatment options. www.tctmd.com/news/new-acc...
New ACC Consensus Document Helps Clinicians Navigate Issues Around TR
It’s meant to support the valve guidelines and aid in disentangling the complexities of the tricuspid field, one of the authors says.
www.tctmd.com